Corticosteroids in relation to fear, anxiety and psychopathology

Neuroscience and Biobehavioral Reviews

Volumn 25, Issue 2, 2001, Pages 117-142

  Korte, S M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Animal welfare; Anxiety; Consolidation; Contextual fear conditioning; Corticosteroids; CRF; Depression; Elevated plus maze test; Fear; Fear extinction; Fear potentiation; Feed forward; Freezing; Glucocorticoid receptor; Hippocampus; Mineralocorticoid receptor; Noradrenaline; Passive avoidance test; Porsolt swim test; Psychopath ology; Serotonin; Stress sensitization

Indexed keywords

ANXIOLYTIC AGENT; CORTICOSTEROID; CORTICOSTEROID RECEPTOR; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR;

ANXIETY; FEAR; FREEZING; HIPPOCAMPUS; HUMAN; MENTAL DISEASE; MENTAL STRESS; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; REVIEW;

ADRENAL CORTEX HORMONES; ANIMALS; ANXIETY DISORDERS; FEAR; HUMANS;

EID: 0035032992     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(01)00002-1     Document Type: Review

References (292)

1. The emergency function of the adrenal medulla in pain and in the major emotions
2. Organization of the stress response at the anatomical level
3. Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour
4. Neuroendocrine correlates of emotional reactivity and coping in male rats fromthe Roman high (RHA/Verh)- and low (RLA/Verh)-avoidance lines
5. Coping styles in animals: current status in behavior and stress-physiology
6. Fear and fearfulness in animals
7. The assessment of fear in the domestic fowl
8. Fear and adaptability in poultry: insights, implications and imperatives
9. The tonic immobility reaction of the domestic fowl: a review
10. Physiological changes during tonic immobility in Gallus gallus var domesticus
11. Allostasis, amygdala, and anticipatory angst
12. Induction of corticotropin-releasing hormone gene expression by glucocorticoids:implication for understanding the states of fear and anxiety and allostaticload
13. From normal fear to pathological anxiety
14. release and avoidance behaviour of rats with cortisol implants inmesencephalic reticular formation and median eminence
15. Adrenocortical hormones and avoidance behaviour of rats
16. The hippocampus and the pituitary-adrenal system hormones
17. Corticosterone-an anxiogenic or an anxiolytic agent?
18. Glucocorticoid-biogenic amine interactions in relation to mood and behavior
19. Brain corticosteroid receptor balance and homeostatic control
20. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze
21. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules
22. Corticotropin-releasing hormone signals adversity in both the placenta and the brain: regulation by glucocorticoids and allostatic overload
23. Pituitary-adrenal alterations and fear responding
24. Pituitary-adrenal influences on fear responding
25. Effect of corticosterone and hydrocortisone on some indicators of anxiety
26. Depressed mood and other psychiatric manifestations of Cushing's syndrome:relationship to hormone levels
27. Cushing's syndrome after treatment: changes in cortisol and ACTH levels, and amelioration of the depressive syndrome
28. Behavioral and cardiac responses after intracerebroventricular corticotropin-releasing hormone (CRH) administration: role of adrenal cortical hormones
29. Central actions of corticotropin-releasing hormone (CRH) on behavioral, neuroendocrine, and cardiovascular regulation: brain corticoid receptor involvement
30. Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety
31. Corticosteroid receptor mediated effects on mood in humans
32. Evidence against the involvement of ACTH/CRF release or corticosteroid receptors in the anxiolytic effect of corticosterone
33. Endocrine effects on the brain and their relationship to behavior
34. Brain mineralocorticoid receptor function
35. Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions
36. Are different parts of the extended amygdala involved in fear versus anxiety?
37. Emotional memory systems in the brain
38. Steroid hormone modulation of hippocampal dependent spatial memory
39. Stress and cognition: are corticosteroids good or bad guys?
40. Glucocorticoids and the regulation of memory consolidation
41. Adrenal steroid receptors and actions in the nervous system
42. Guanyl nucleotides modulate binding to steroid receptors in neuronal membranes
43. Selective retention of corticosterone by limbic structures in rat brain
44. Glucocorticoid signalling-multiple variations of a common theme
45. The brain as a target for steroid hormone action
46. Stress hormones: their interaction and regulation
47. Adrenal steroids and behavioral adaptation: relationship to brain corticoid receptors
48. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation
49. Central glucocorticoid receptor immunoreactive neurons: new insights into the endocrine regulation of the brain
50. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- anddiencephalon using a monoclonal antibody against rat liver glucocorticoidreceptor
51. Vale W,Gustafsson JA Presence of glucocorticoid receptor immunoreactivity in corticotrophin releasingfactor and in growth hormone releasing factor immunoreactive neurons of the ratdi- and telencephalon
52. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain
53. Immunocytochemical study on the intracellular localization of the type 2 glucocorticoid receptor in the rat brain
54. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation
55. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus
56. Glucocorticoid receptor-immunoreactivity in C1, C2, and C3 adrenergic neurons that project to the hypothalamus or to the spinal cord in the rat
57. Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis
58. Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation
59. Differential response of type 1 and type 2 corticosteroid receptors to changes in plasma steroid level and circadian rhythmicity
60. Corticosteroid effects on electrical properties of brain cells: temporal aspects and role of antiglucocorticoids
61. Stress, glucocorticoids, and damage to the nervous system: the current state of confusion
62. Glucocorticoids facilitate the retention of acquired immobility during forced swimming
63. Antiglucocorticoid RU38486 attenuates retention of a behaviour and disinhibits the hypothalamicpituitary adrenal axis at different brain sites
64. Pituitary-adrenal system hormones and adaptive behaviour
65. Footshock sensitivity of rats after adrenalectomy and glucocorticoid treatments
66. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of adrenocortical steroid biosynthesis
67. Dose-dependent suppression of adrenocortical activity with metyrapone: effects on emotion and memory
68. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibitsthe human pituitary-adrenal system at a specific time of day
69. RU 38486: potent antiglucocorticoid activity correlated with strong binding tothe cytosolic glucocorticoid receptor followed by an impaired activation
70. Why dexamethasone poorly penetrates in brain
71. Decreased glucocorticoid receptor activity following glucocorticoid receptorantisense RNA gene fragment transfection
72. Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test
73. Increased stress-induced adrenocorticotropin response after long-termintracerebroventricular treatment of rats with antisense mineralocorticoidreceptor oligodeoxynucleotides
74. Organizing action of corticosterone on the development of behavioral inhibition in the preweanling rat
75. Stimulus control of behavioral inhibition in the preweanling rat
76. Glucocorticoids and the hippocampus. Developmental interactions facilitating the expression of behavioral inhibition
77. Corticosteroid induction of threat-induced behavioral inhibition in preweanling rats
78. The ontogeny of the hypothalamic-pituitary-adrenal axis. The influence of maternal factors
79. Intracranial action of corticosterone facilitates the development of behavioral inhibition in the adrenalectomized preweanling rat
80. Glucocorticoids, the hippocampus, and behavioral inhibition in the preweanling rat
81. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
82. Anxiogenic stimuli in the elevated plus-maze
83. The influence of open arm ledges and maze experience in the elevated plus-maze
84. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety
85. Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat
86. Corticosterone is permissive to the anxiolytic effect that results from the blockade of hippocampal mineralocorticoid receptors
87. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action
88. Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity
89. The role of corticotropin-releasing factor in behavioural responses to stress
90. Fear-potentiation in the elevated plus-maze test depends on stressor controllability and fear conditioning
91. Retention of a passive avoidance response is a function of the intensity and duration of electric shock
92. Conditioned neuroendocrine and cardiovascular stress responsiveness accompanying behavioral passivity and activity in aged and in young rats
93. Fear-potentiated startle: a neural and pharmacological analysis
94. Anxiolytics and stress-induced behavioural and cardiac responses: a study of diazepam and ipsapirone (TVX Q 7821)
95. Lesions of the dorsal hippocampal formation interfere with background but not foreground contextual fear conditioning
96. Contextual fear, gestalt memories, and the hippocampus
97. Limbic-midbrain mechanisms and behavioral physiology interactions with CRF, ACTH and adrenal hormones
98. Adrenal steroids and extinction behavior: antagonism by pogesterone, deoxycorticosterone and dexamethasone of a specific effect of corticosterone
99. Pituitary-adrenal hormones and the forced extinction of a passive avoidance response in the rat
100. Depression: a new animal model sensitive to antidepressant treatments
101. Corticosterone influences forced swim-induced immobility
102. Long-term antidepressant treatment reduces behavioural deficits in transgenicmice with impaired glucocorticoid receptor function
103. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression
104. Learned immobility explains the behavior of rats in the forced swimming test
105. Behavioural effect of adrenalectomy: reversal by glucocorticoids or[D-Ala2,Met5]enkephalinamide
106. Glucocorticoids, adrenal medullary opioids, and the retention of a behavioralresponse after stress
107. Ontogeny of the stress response in the rat: role of the pituitary and the hypothalamus
108. Adrenal and plasma corticosterone and vitamin A in rat adrenal glands during postnatal development
109. Biochemical effects of corticosteroids on neural tissues
110. Maternal regulation of the hypothalamic-pituitary-adrenal axis in the infant rat: the roles of feeding and stroking
111. de Kloet Ontogeny of mineralocorticoid (type 1) receptors in brain and pituitary: an in vivo autoradiographical study
112. Ontogeny of corticosteroid receptors in the brain
113. Ontogeny of the type 2 glucocorticoid receptor in discrete rat brain regions: an immunocytochemical study
114. Prenatal stress: consequences of glucocorticoids on hippocampal development and function
115. Presynaptic muscarinic cholinergic receptors in the dorsal hippocampus regulate behavioral inhibition of preweanling rats
116. A theory of anxiety: the role of the limbic system
117. Behavioural and neural-system analyses of the actions of anxiolytic drugs
118. Stress and behavioural inhibition
119. Cognitive dysfunction resulting from hippocampal hyperactivity-a possible cause of anxiety disorder?
120. Regulation of hippocampal theta activity by corticosterone: opposing functions of mineralocorticoid and glucocorticoid receptors
121. Muscarinic antagonists are anxiogenic in rats tested in the Black-White box
122. The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the Black-White box test
123. Corticosterone modifies muscarinic receptor immunoreactivity in rat hippocampus
124. Cholinergic responsiveness of rat CA1 hippocampal neurons in vitro: modulation by corticosterone and stress
125. Plasma catecholamine and corticosterone levels during active and passive shock-prod avoidance behavior in rats: effects of chlordiazepoxide
126. The effect of ipsapirone on behavioural and cardiac responses in the shock-probe/defensive burying test in male rats
127. The effects of early rearing environment on the development of GABAA and central benzodiazepine receptor levels and novelty-induced fearfulness in the rat
128. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
129. Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats
130. The acute effects of corticosteroids on cognition: integration of animal and human model studies
131. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems
132. Corticosterone response to the plus-maze: high correlation with risk assessmentin rats and mice
133. Attack and defense in rodents as ethoexperimental models for the study of emotion
134. Corticosterone is involved in foot shock-induced inactivity in rats
135. The effects of corticosteroids and ACTH on sensory systems
136. Taste thresholds in man are differentially influenced by hydrocortisone anddexamethasone
137. Auditory reflex thresholds elevated by stress-induced cortisol secretion
138. Differential effects of glucocorticoids on human auditory perception
139. Memory-a century of consolidation
140. Corticosteroid receptor antagonists are amnestic for passive avoidance learning in day-old chicks
141. Corticosterone enhances long-term retention in one-day-old chicks trained in a weak passive avoidance learning paradigm
142. Selective corticosteroid antagonists modulate specific aspects of spatialorientation learning
143. Attenuated cardiovascular, neuroendocrine, and behavioral responses after a single footshock in central amygdaloid lesioned male rats
144. Central amygdala lesions affect behavioral and autonomic balance during stress in rats
145. The role of the central amygdala in stress and adaption
146. Behavioral, neuroendocrine, and immunological outcomes of escapable or inescapable shocks
147. Fear conditioned with escapable and inescapable shock: the effects of a feedback stimulus
148. The role and mechanisms of action of glucocorticoid involvement in memory storage
149. A role for brain glucocorticoid receptors in contextual fear conditioning: dependence upon training intensity
150. Correlational relationship between shock intensity and corticosterone secretion on the establishment and subsequent expression of contextual fear conditioning
151. Training-dependent biphasic effects of corticosterone in memory formation for a passive avoidance task in chicks
152. glucocorticoid receptor antagonists impair contextual but not auditory-cue fear conditioning in juvenile rats
153. A selective role for corticosterone in contextual-fear conditioning
154. Glucocorticoid receptor agonist and antagonist administration into the basolateral but not central amygdala modulates memory storage
155. Basolateral amygdala noradrenergic influence enables enhancement of memory consolidation induced by hippocampal glucocorticoid receptor activation
156. Glucocorticoid receptor activation in the rat nucleus of the solitary tract facilitates memory consolidation: involvement of the basolateral amygdala
157. Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fear
158. Differential contribution of amygdala and hippocampus to cued and contextualfear conditioning
159. Is the hippocampus necessary for contextual fear conditioning?
160. Emotion: clues from the brain
161. Posttrial injections of corticosterone in dorsal hippocampus of the BALB/cmouse facilitate extinction of appetitive operant conditioning in the Skinnerbox
162. tamine and the mediation of pituitary-adrenocortical hormones in the extinction of active avoidance behaviour
163. Blockade of corticosterone synthesis reduces serotonin turnover in the dorsal hippocampus of the rat as measured by microdialysis.
164. Central nervous structures and the effect of ACTH and corticosteroids on avoidance behavior: a study with intracerebral inplantation of corticosteroids in the rat
165. Dorsal bundle extinction effect: motivation or attention?
166. Opposite effects on hippocampal corticosteroid receptors induced by stimulation of beta and alpha 1 noradrenergic receptors
167. Metyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress
168. Corticosterone potentiation of conditioned fear in rats
169. Tonic immobility and heterophil/lymphocyte responses of the domestic fowl to corticosterone infusion
170. Fear and distress in Japanese quail chicks of two lines genetically selected for low or high adrenocortical response to immobilization stress
171. Fear of humans in Japanese quail selected for low or high adrenocortical response
172. Threat-induced behavioural inhibition in Japanese quail genetically selected for contrasting adrenocortical response to mechanical restraint
173. Individual differences in freezing and cortisol in infant and mother rhesusmonkeys
174. Biological bases of childhood shyness
175. Behavioral and neuroendocrine responses in shy children
176. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
177. Effects of acute prednisone administration on memory, attention and emotion inhealthy human adults
178. 1A autoreceptors in the raphe nuclei
179. 1A receptor agonist ipsapirone in the rat: neurobiological correlates
180. Potential anxiolytic properties of R-(+)-8-OSO2CF3-PAT, a 5-HT 1A receptor agonist
181. Corticosterone regulation of tryptophan hydroxylase in midbrain of the rat
182. Adrenalcortical influence on rat brain tryptophan hydroxylase activity
183. Increase of tryptophan hydroxylase enzyme protein by dexamethasone in adrenalectomized rat midbrain
184. Serotonergic responses to corticosterone and testosterone in the limbic system
185. Increase in the activity of tryptophan hydroxylase from cortex and midbrain of male Fischer 344 rats in response to acute or repeated sound stress
186. In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: significant enhancement by immobilization stress in rats
187. Increases in the activity of tryptophan hydroxylase from rat cortex and midbrain in response to acute or repeated sound stress are blocked by adrenalectomy and restored by dexamethasone treatment
188. Sound stress activation of tryptophan hydroxylase blocked by hypophysectomy and intracanial RU 38486
189. Glucocorticoid receptor-mediated inhibition by corticosterone of 5-HT1A autoreceptor functioning in the rat dorsal raphe nucleus
190. 1A autoreceptor sensitivity inthe rat dorsal raphe nucleus-in vitro electrophysiological evidence
191. Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF)
192. Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus
193. Distribution of corticotropin-releasing factor receptor mRNA expression in therat brain and pituitary
194. The role of CRF in behavioral aspects of stress
195. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
196. Role of the hippocampus, the bed nucleus of the stria terminalis, and theamygdala in the excitatory effect of corticotropin-releasing hormone on theacoustic startle reflex
197. Increased mRNA for corticotrophin releasing hormone in the amygdala of fawn-hooded rats: a potential animal model of anxiety
198. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat
199. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus
200. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus
201. Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress
202. Region-specific regulation of neuropeptide mRNAs in rat limbic forebrain neurones by aldosterone and corticosterone
203. Alterations in corticotropin-releasing hormone gene expression of central amygdaloid neurons following long-term paraventricular lesions and adrenalectomy
204. Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus
205. Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus: An in situ hybridization analysis
206. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis
207. Corticosterone delivery to the amygdala increases corticotropin-releasing factormRNA in the central amygdaloid nucleus and anxiety-like behavior
208. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism andcorticotropin-releasing hormone
209. The role of corticotropin-releasing factor in the pathophysiology of affectiveand anxiety disorders: laboratory and clinical studies
210. Corticotropin-releasing factor, norepinephrine, and stress
211. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors
212. The role of corticotropin-releasing factor in depression and anxiety disorders
213. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims
214. Corticotropin releasing factor produces behavioural activation in rats
215. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?
216. SwaabDFCorticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression
217. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress
218. Brain corticosteroid receptor balance in health and disease
219. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system
220. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-termtreatment with the reversible monoamine oxidase-A inhibitor moclobemide
221. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNAexpression in rat hippocampus in vivo
222. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?
223. Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement
224. Repeated administration of the combined dexamethasone-human corticotropinreleasing hormone stimulation test during treatment of depression
225. Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486
226. Ketoconazole administration in hypercortisolemic depression
227. Treatment of major depression with metyrapone and hydrocortisone
228. Dinan TGCortisol synthesis inhibition: a new treatment strategy for the clinical andendocrine manifestations of depression
229. Antiglucocorticoid therapies in major depression: a review
230. Treatment of depression with antiglucocorticoid drugs
231. Enhanced suppression of cortisol following dexamethasone administration inposttraumatic stress disorder
232. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis
233. Elevated CSF corticotropin-releasing factor concentrations in posttraumaticstress disorder
234. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder
235. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder
236. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse-a preliminary report
237. Hippocampal volume reduction in major depression
238. Hippocampal atrophy in recurrent major depression
239. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression
240. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death
241. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients
242. Wellman MMMonoamines: biochemical markers of suicide?
243. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study
244. Further studies on platelet serotonin transporter binding in depression
245. Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediatedhypothermic response to ipsapirone in unipolar depression
246. 5-HT1A receptor responsivity in unipolar depression. Evaluation ofipsapirone-induced ACTH and cortisol secretion in patients and controls
247. Serotonin type-1A receptor imaging in depression
248. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity
249. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors
250. Sex differences in depression: a role for preexisting anxiety
251. Early onset depression: the relevance of anxiety
252. Prevalence of anxiety disorders and their comorbidity with mood and addictivedisorders
253. McLean Hospital depression research facility: early-onset phobic disorders and adult-onset major depression
254. Anxiety and depression: a common neurobiological substrate?
255. New indications for antidepressants
256. Psychosocial stress in tree shrews: clomipramine counteracts behavioral and endocrine changes
257. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3pyramidal neurons in subordinate tree shrews
258. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation
259. Hippocampal glucocorticoid receptor expression in the tree shrew: regulation by psychosocial conflict
260. Modulation of binding sites for corticotropin-releasing hormone by chronic psychosocial stress
261. Beta-adrenoceptors in the tree shrew brain. II. Time-dependent effects ofchronic psychosocial stress on [125I]iodocyanopindolol bindings sites
262. Monoamine receptors in the prefrontal cortex of Tupaia belangeri during chronicpsychosocial stress
263. Dynamics of central nervous 5-HT1A-receptors under psychosocial stress
264. Single social interaction leading to defeat in male rats induces a gradual, but long lasting behavioral change: a model of depression?
265. The temporal dynamics of the stress response
266. Social stress in rats and mice
267. Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRFchallenge in socially defeated rats
268. Socially defeated male rats display a blunted adrenocortical response to a lowdose of 8-OH-DPAT
269. Corticosterone suppresses the expression of 5-HT1A receptor mRNA in rat dentategyrus
270. A role for the mineralocorticoid receptor in a rapid and transient suppression of hippocampal 5-HT1A receptor mRNA by corticosterone
271. Regulation of hippocampal 5-HT1A receptor mRNA and binding in transgenic micewith a targeted disruption of the glucocorticoid receptor
272. 5HT1A-receptors and behaviour under chronic stress: selective counteraction by testosterone
273. Regulation of serotonin1A, glucocorticoid, andmineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression
274. Differential regulation of hippocampal glucocorticoid receptors mRNA and fast feeback: relevance to post-traumatic stress disorder
275. Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat
276. Prenatal stress increases the hypothalamo-pituitary-adrenal axis response in young and adult rats
277. Maternal glucocorticoid secretion mediates long-term effects of prenatal stress
278. Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion
279. Hyper-reactive hypothalamo-pituitary-adrenocortical axis in rats bred for highanxiety-related behaviour
280. Increased basal activity of the hypothalamo-pituitary-adrenal axis during pregnancy in rats bred for high anxiety-related behaviour
281. Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study
282. Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress
283. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress
284. Regulation of glucocorticoid and mineralocorticoid receptor mRNAs in the hippocampus of the maternally deprived infant rat
285. Persistent effects of maternal deprivation on HPA regulation can be reversed by feeding and stroking, but not by dexamethasone
286. Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat
287. Regulation of hippocampal glucocorticoid receptor gene transcription and protein expression in vivo
288. Corticosterone regulation of type I and type II adrenal steroid receptors inbrain, pituitary, and immune tissue
289. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response
290. Transactivation and synergistic properties of the mineralocorticoid receptor:relationship to the glucocorticoid receptor
291. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications
292. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated